Correlation Between Israel China and Clal Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and Clal Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Clal Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and Clal Insurance Enterprises, you can compare the effects of market volatilities on Israel China and Clal Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Clal Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Clal Insurance.

Diversification Opportunities for Israel China and Clal Insurance

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Israel and Clal is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Clal Insurance Enterprises in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Insurance Enter and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Clal Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Insurance Enter has no effect on the direction of Israel China i.e., Israel China and Clal Insurance go up and down completely randomly.

Pair Corralation between Israel China and Clal Insurance

Assuming the 90 days trading horizon Israel China Biotechnology is expected to generate 14.07 times more return on investment than Clal Insurance. However, Israel China is 14.07 times more volatile than Clal Insurance Enterprises. It trades about 0.12 of its potential returns per unit of risk. Clal Insurance Enterprises is currently generating about -0.3 per unit of risk. If you would invest  65,000  in Israel China Biotechnology on January 20, 2024 and sell it today you would earn a total of  12,000  from holding Israel China Biotechnology or generate 18.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy94.74%
ValuesDaily Returns

Israel China Biotechnology  vs.  Clal Insurance Enterprises

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Israel China Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Israel China sustained solid returns over the last few months and may actually be approaching a breakup point.
Clal Insurance Enter 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Clal Insurance Enterprises are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Clal Insurance may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Israel China and Clal Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and Clal Insurance

The main advantage of trading using opposite Israel China and Clal Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Clal Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Insurance will offset losses from the drop in Clal Insurance's long position.
The idea behind Israel China Biotechnology and Clal Insurance Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals